3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Oligodendroglioma
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Astrocytoma
1
Interventions
Temozolomide
45
Radiotherapy
20
Filgrastim
17
Carmustine
15
Carboplatin
15
Irinotecan
13
Bevacizumab
13
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
11
Peripheral Blood Stem Cell Transplantation
9
Erlotinib Hydrochloride
9
sargramostim
8
O(6)-benzylguanine
8
Radiation
7
Topotecan
6
Thiotepa
6
Radiotherapy, Intensity-Modulated
6
Procarbazine
6
Etoposide
6
Drug Therapy
6
Cyclophosphamide
6
Chemotherapy, Adjuvant
6
aldesleukin
5
Vorinostat
5
Sirolimus
5
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
temsirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
picropodophyllin
×
Sarcoma
×
Clear all
NCT01721577
2023-05-22
AXL1717
Rush University Medical Center
Phase 1/2
Terminated
10 enrolled
8 charts